Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


ALKERMES reported $-47494000 in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
AbbVie ABBV:US USD 2.77B 2.73B
Acadia Pharmaceuticals ACAD:US USD -53584000 7.52M
Acorda Therapeutics ACOR:US USD -11476000 38.88M
Amgen AMGN:US USD 2.03B 196M
Biogen BIIB:US USD 507.7M 192.2M
BioMarin Pharmaceutical BMRN:US USD 59.35M 83.85M
Bluebird Bio BLUE:US USD 8.44M 17M
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Coherus Biosciences CHRS:US USD -67745000 16.25M
Eli Lilly LLY:US USD 1.49B 342.4M
Gilead Sciences GILD:US USD 1.7B 562M
Heron Therapeutics HRTX:US USD -33063000 12.71M
Horizon Pharma HZNP:US USD 35.99M 137.94M
Intra Cellular Therapies ITCI:US USD -48392000 980K
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
J&J JNJ:US USD -737000000 4.94B
Marinus Pharmaceuticals MRNS:US USD -32963000 2.95M
Merck & Co MRK:US USD 3.72B 286M
Minerva Neurosciences NERV:US USD -5349000 279K
Nektar Therapeutics NKTR:US USD -134710000 82.24M
Neurocrine Biosciences NBIX:US USD -114200000 217.6M
Otsuka Holdings 4578:JP JPY 76.78B 41.3B
Pfizer PFE:US USD 6.79B 1.62B
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Revance Therapeutics RVNC:US USD -58032000 86.38M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M